Iprofayile yekhampani
Yasekwa eBeijing ngoSeptemba ka-1995, iBeijing Beier Bioengineering Co., Ltd. lishishini lobugcisa obuphezulu e-China eligxile ekuphuhliseni nasekuveliseni i-in vitro diagnostic reagents.
Utshintsho lwetekhnoloji ibisoloko iyinto yokuqala yokuqhubela phambili uphuhliso oluqhubekayo lwenkampani.Emva kweminyaka engaphezu kwe-20 yophando oluzimeleyo kunye nophuhliso, i-Beier iye yakha i-multi-type kunye ne-multi-project integration technology platforms, kubandakanywa i-magnetic particle chemiluminescence diagnostic reagent, i-ELISA i-diagnostic reagent platform, i-colloidal yegolide ye-POCT yokuxilonga ngokukhawuleza, i-PCR i-molecular diagnostic reagent, i-biochemical diagnostic reagent, kunye nokuveliswa kwezixhobo.Ukuba sele yenze umgca wemveliso opheleleyo ogubungela iintsholongwane zokuphefumla, ukhathalelo lwangaphambi kokubeleka kunye nasemva kokubeleka, i-hepatitis, i-virus ye-Epstein-Barr, i-autoantibodies, iziphawuli zethumba, umsebenzi wedlala lengqula, i-fibrosis yesibindi, uxinzelelo lwegazi, kunye nezinye iinkalo.
Inzuzo Yethu
Ukusukela ekusekweni kwayo, ingeniso yokuthengisa iqhubekile nokukhula, kwaye ngokuthe ngcembe iye yaba yenye yeenkampani zemveliso yasekhaya ye-vitro yokuqala eTshayina.
Ubudlelwane beNtsebenziswano
Njengenye yeenkampani ezinoluhlu olupheleleyo lweemveliso ze-immunodiagnostic kwishishini, i-Beier ifikelele kubudlelwane bentsebenziswano bexesha elide kunye nezibhedlele ezingaphezu kwe-10,000 kunye namaqabane angaphezu kwe-2,000 ngaphakathi nangaphandle kwe-China.
Isabelo seMarike esiPhakamileyo
Phakathi kwazo, ii-reagents zokuxilonga kwi-pathogens yokuphefumla, intsholongwane ye-Epstein-Barr kunye nokhathalelo lwangaphambi kokubeleka kunye nasemva kokubeleka ziimveliso zokuqala ezivunyiweyo ukuba zithengiswe eTshayina, zibekwe phakathi kwezona zithathu ziphezulu kwisabelo semalike yasekhaya kwaye ziye zaqhawuka kwimo yoyedwa yeemveliso ezithunyelwa ngaphandle eTshayina.
Phuhlisa kakuhle
I-Beier ithatha impilo yomntu njengomsebenzi wayo kwaye igxile ekuphononongeni iindawo ezintsha zokubona.Okwangoku, i-Beier yenze ipateni yophuhliso lweqela kunye nophuhliso oluhlukeneyo lwamaqonga emveliso.
Imbali yeNkampani
-
- Ngo-1995, ukusekwa njengeshishini lobuchwepheshe obuphezulu.
1995 -
- Kwi-1998, "Ikiti yokuhlola i-Chorionic Gonadotropin yomntu (i-Colloidal Gold)" yavunywa nguMphathiswa wezeMpilo.
1998 -
- Kwi-1999, yathatha iNkqubo yeSizwe ye-863 "uPhando kwi-Specific Gene Diagnostic Reagents ye-Pathogenic Microorganisms" ukuphuhlisa i-Helicobacter pylori antibody ELISA kit.
1999 -
- Kwi-2001, inkampani yokuqala e-China ukufumana ukubhaliswa kwe-"Anti-Helicobacter pylori antibody ELISA kit".
2001 -
- Kwi-2005, i-GMP iqinisekisiwe.
2005 -
- Kwi-2006, inkampani yokuqala e-China ukufumana ukubhaliswa kwe "Human Cytomegalovirus IgM Antibody ELISA Kit ".
2006 -
- Kwi-2007, inkampani yokuqala e-China ukufumana ukubhaliswa kwe-"EB VCA antibody (IgA) ELISA kit".
2007 -
- Kwi-2008, inkampani yokuqala e-China ukufumana ukubhaliswa "kwemveliso ye-10 ye-TOCH ELISA kunye nezinto ezi-4 ze-TORCH-IgM Rapid test".
2008 -
- Kwi-2009, inkampani yokuqala e-China ukufumana ukubhaliswa kwe-" Test Kit for Hepatitis D Virus".
2009 -
- Kwi-2010, inkampani yokuqala e-China ukufumana ukubhaliswa kwe-"Enterovirus 71 IgM / IgG ELISA kit".Isiqinisekiso se-GMP okwesibini.
2010 -
- Kwi-2011, iprojekthi ye-"Giant Cell Recombinant Antigen" iphumelele ibhaso lesithathu leSayensi kunye neTekhnoloji yeNkqubela yeMbasa.
2011 -
- Kwi-2012, inkampani yokuqala ukufumana ukubhaliswa kwe "EB virus series kit test (Enzyme-linked Immunoassay)" yokuxilongwa kwesifo se-monocyte esosulelayo.
2012 -
- Kwi-2013, inkampani yokuqala ukufumana ukubhaliswa kwe-Coxsackie Group B virus ye-IgM / IgG ELISA ikiti yokufumanisa i-myocarditis yentsholongwane.
2013 -
- Kwi-2014, yenze uphuhliso lweekiti zokufumanisa i-pathogen yokuphefumula kwiprojekthi yesizwe yeshumi elinesibini yeminyaka emihlanu ephambili yophando "i-AIDS kunye neProjekthi yeZifo ezosulelayo eziMkhulu".Yayiyinkampani yokuqala e-China ukufumana ukubhaliswa kwee-pathogens ze-12 zokuphefumla ze-IgM / IgG zokuvavanya i-antibody.
2014 -
- Kwi-2015, inkampani yokuqala e-China ukufumana ukubhaliswa kwe-"streptococcus pneumoniae antigen test kit" kwaye yagqiba isiqinisekiso se-GMP sesithathu.
2015 -
- Ngo-2016, "i-EV71 virus IgM test kit" iphumelele ibhaso lesithathu leBeijing Science and Technology Progress."Uphando kunye nophuhliso kunye nokusetyenziswa kwe-pathogenic microorganism series reagents kunye nobuchwepheshe" iphumelele ibhaso lokuqala le-Jiangsu Pharmaceutical Science and Technology Progress.Uphumelele uvavanyo lwesiqinisekiso se-ISO13485.
2016 -
- • Ngo-2017, yenze uphuhliso lwee-reagents zokuxilonga kwizifo ezisulelayo ngokukhawuleza kwi-National 13th yeminyaka emihlanu yeProjekthi ePhambili "UkuThintelwa kunye noLawulo lweZifo eziNxibelelayo eziNtsholongwane ezifana ne-AIDS kunye ne-Viral Hepatitis".
2017 -
- Kwi-2018, ifumene i-TORCH 10 (i-Magneto particle Chemiluminescence) ukubhaliswa kwemveliso.
2018 -
- Ngo-2019, inkampani yokuqala yasekhaya ukufumana ukubhaliswa kweentsholongwane zokuphefumla (imagnetic particle chemiluminescence).Ngo-2019, kufunyenwe ukubhaliswa kwentsholongwane ye-EB (imagnetic particle chemiluminescence) iimveliso zothotho.
2019 -
- Ngo-2020, senza iprojekthi yengxamiseko yeKomishoni kaMasipala weSayensi kunye neTekhnoloji yaseBeijing "R & D yeNew Coronavirus (2019-nCoV) Antibody Rapid Test Cassette".Uvavanyo oluKhawulezayo lwe-COVID-19 Antigen lufumene ubhaliso lwe-CE, oluhlangabezana nesiqinisekiso sokufikelela kwi-EU.Kufunyenwe ukubhaliswa kweemveliso zokulawula umgangatho we-eugenic 10 izinto.
2020 -
- Ngo-2021, inkampani yokuqala e-China ukufumana ukubhaliswa kwezinto ezi-9 zeemveliso zokulawula umgangatho we-IgM antibody kwi-pathogens yosulelo lokuphefumla.I-COVID-19 Antigen Rapid Test ifumene isatifikethi se-CE sokuzivavanya kwi-PCBC.
2021 -
- Ngo-2022, uVavanyo oluKhawulezayo lwe-COVID-19 lwangena kuluhlu lwe-EU oluqhelekileyo kuluhlu A.
2022
